| タイトル | Pharmacologic considerations for Shuttle astronauts |
| 著者（英） | Santy, Patricia A.; Bungo, Michael W. |
| 著者所属（英） | NASA Johnson Space Center |
| 発行日 | 1991-10-01 |
| 言語 | eng |
| 内容記述 | Medication usage by crewmembers in the preflight and inflight mission periods is common in the Shuttle Program. The most common medical reports for which medication is used are: space motion sickness (SMS), sleeplessness, headache, and backache. A number of medications are available in the Shuttle Medical Kit to treat these problems. Currently, astronauts test all frequently used medications before mission assignment to identify potential side-effects, problems related to performance, personal likes/dislikes, and individual therapeutic effect. However, microgravity-induced changes in drug pharmacokinetics, in combination with multiple operational factors, may significantly alter crewmember responses inflight. This article discusses those factors that may impact pharmacologic efficacy during Shuttle missions. |
| NASA分類 | AEROSPACE MEDICINE |
| レポートNO | 93A17537 |
| 権利 | Copyright |
| URI | https://repository.exst.jaxa.jp/dspace/handle/a-is/321776 |
|
